Panacor currently has three products under development, Nephoxil^TM , PB1612 and PB1603.

• Nephoxil^TM : for treatment of hyperphosphatemia in ESRD patients.
  

• PB1612 : to combat soft tissue calcification in renal failure patients.

• PB1603 : to combat Chronic Kidney Disease (“CKD”).